In his keynote speech at Ending Age-Related Diseases 2020, Dr. Aubrey de Grey of SENS Research Foundation discusses the current state of the rejuvenation biotechnology industry in the context of the current pandemic. He mentions the failure of Unity Biotechnology’s Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology, XPRIZE, and the steps that are currently being taken towards a world without age-related diseases.
HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Apigenin is a flavonoid, a compound found in various plants, and is the aglycone of several naturally occurring glycosides. It is solid and crystalline in structure with a yellow color to it. Apigenin can […]
A massive RNA sequencing effort has identified changes in microRNA associated with Parkinson’s. Some of the changes correlated with disease progression, holding out hope that they could be useful as prognostic or diagnostic […]
When conducting science, it is crucially important to have clear, unambiguous definitions. These definitions must be firmly established to avoid confusion and misunderstandings and possibly to prevent people from going around telling everyone that you’re working on something that […]
The UK All Party Parliamentary Group for Longevity (APPG) launched the Levelling Up Health initiative recently. The initiative aims to close the life expectancy […]
A new study in Molecular Cell has shown that the benefits of hypoxia may be derived from a suppression of the inflammatory SASP. Can less oxygen be a good thing? Cell cultures are typically maintained in conditions […]
This week on Lifespan News, Brent Nally discusses how the GrimAge clock, an accurate predictor of age of death, shows that major depression accelerates aging. […]
You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.
Write a comment: